AbbVie (ABBV) Work In Process (2012 - 2016)
AbbVie (ABBV) posted quarterly Work In Process of $1.1 billion for Q2 2016, up 4.81% year-over-year from $1.0 billion in Q3 2015, and down 1.29% quarter-over-quarter from $1.1 billion in Q1 2016.
AbbVie (ABBV) Work In Process (2012 - 2016) Analysis & Trends
AbbVie (ABBV) has reported Work In Process for 5 consecutive years, with $1.1 billion the latest figure, recorded in Q2 2016.
- In Q2 2016, Work In Process rose 4.81% year-over-year to $1.1 billion; the TTM figure through Jun 2016 stood at $1.1 billion (up 4.81% YoY), while the FY2015 annual figure was $1.1 billion, up 71.86% from the prior year.
- Work In Process retreated to $1.1 billion in Q2 2016 per ABBV's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Work In Process topped out at $1.1 billion in Q1 2016 and bottomed at $262.0 million in Q1 2013.
- Historically, Work In Process has averaged $672.0 million across 5 years, with a median of $568.0 million in 2015.
- Annual changes were most pronounced in 2015 — Work In Process surged 122.85% — and 2016, when it gained 4.81%.
- AbbVie's Work In Process stood at $286.0 million in 2012, then surged by 41.26% to $404.0 million in 2013, then surged by 55.69% to $629.0 million in 2014, then surged by 71.86% to $1.1 billion in 2015, then dropped by 1.2% to $1.1 billion in 2016.
- Business Quant data shows ABBV's Work In Process at $1.1 billion in Q2 2016, $1.1 billion in Q1 2016, and $1.1 billion in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 1.07 Bn |
| Mar 31, 2016 | 1.08 Bn |
| Dec 31, 2015 | 1.08 Bn |
| Sep 30, 2015 | 1.06 Bn |
| Jun 30, 2015 | 1.02 Bn |
| Mar 31, 2015 | 568.00 Mn |
| Dec 31, 2014 | 629.00 Mn |
| Sep 30, 2014 | 477.00 Mn |
| Dec 31, 2013 | 404.00 Mn |
| Sep 30, 2013 | 439.00 Mn |
| Jun 30, 2013 | 358.00 Mn |
| Mar 31, 2013 | 262.00 Mn |
| Dec 31, 2012 | 286.00 Mn |